MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3

Cellular Physiology and Biochemistry

Volumn 39, Issue 3, 2016, Pages 1165-1176

  Wei, Wei ^a   Yang, Yang ^b,c   Cai, Jian ^b   Cui, Kai ^a   Li, Rong Xian ^a   Wang, Huan ^a   Shang, Xiujuan ^a   Wei, Dong ^b  

^a Department of Gastroenterology   (China)

^b No 150 Central Hospital of PLA   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Integrin 3; Metastasis; MiRNA 30a 5p

Indexed keywords

BETA3 INTEGRIN; MICRORNA; MICRORNA 30A 5P; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ITGB3 PROTEIN, HUMAN; LUCIFERASE; MIRN30 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CELL MIGRATION; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSWELL ASSAY; TUMOR INVASION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; LIVER TUMOR; METABOLISM; PATHOLOGY; REPORTER GENE; SECONDARY; SIGNAL TRANSDUCTION; SPLEEN TUMOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HEK293 CELLS; HUMANS; INTEGRIN BETA3; LIVER NEOPLASMS; LUCIFERASES; MICE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; SPLENIC NEOPLASMS;

EID: 84986906282     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000447823     Document Type: Article

References (49)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
2. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19:92-105.
3. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-9632.
4. Chen CZ, Li L, Lodish HF, Bartel DP: MicroRNAs modulate hematopoietic lineage differentiation. Science 2004;303:83-86.
5. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E: let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007;131:1109-1123.
6. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P, Song E: MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009;15:3998-4008.
7. Yu F, Deng H, Yao H, Liu Q, Su F, Song E: Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 2010;29:4194-4204.
8. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schuler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009;11:1487-1495.
9. Paterson EL, Kazenwadel J, Bert AG, Khew-Goodall Y, Ruszkiewicz A, Goodall GJ: Down-Regulation of the miRNA-200 Family at the Invasive Front of Colorectal Cancers with Degraded Basement Membrane Indicates EMT Is Involved in Cancer Progression 1 2. Neoplasia 2013;15:180-191.
10. Liu MX, Zhou KC, Cao Y: MCRS1 overexpression, which is specifically inhibited by miR-129∗, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer. Mol Cancer 2014;13:245.
11. Couzin J: Cancer biology. A new cancer player takes the stage. Science 2005;310:766-767.
12. Andrea V, Tyler J: MicroRNAs and cancer: short RNAs go a long way. Cell 2009;136:586-591.
13. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
14. Xia X, Yang B, Zhai X, Liu X, Shen K, Wu Z, Cai J: Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. PLoS One 2013;8:e80426.
15. Zhang J, Lu Y, Yue X, Li H, Luo X, Wang Y, Wang K, Wan J: MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS One 2013;8:e70300.
16. Lou X, Qi X, Zhang Y, Long H, Yang J: Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer. J Surg Oncol 2013;108:230-235.
17. Zhou C, Liu G, Wang L, Lu Y, Yuan L, Zheng L, Chen F, Peng F, Li X: MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1. PLoS One 2013;8:e63142.
18. Ye J, Wu X, Wu D, Wu P, Ni C, Zhang Z, Chen Z, Qiu F, Xu J, Huang J: miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer. PLoS One 2013;8:e60687.
19. Zhang W, Zou C, Pan L, Xu Y, Qi W, Ma G, Hou Y, Jiang P: MicroRNA-140-5p inhibits the progression of colorectal cancer by targeting VEGFA. Cell Physiol Biochem 2015;37:1123-1133.
20. Xu K, Liu X, Mao X, Xue L, Wang R, Chen L, Chu X: MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1. Cell Physiol Biochem 2015;35:499-515.
21. Fang Y, Sun B, Xiang J, Chen Z: MiR-301a promotes colorectal cancer cell growth and invasion by directly targeting SOCS6. Cell Physiol Biochem 2015;35:227-236.
22. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, Jr., Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, Raymond CK, Roberts BS, Juhl H, Kinzler KW, Vogelstein B, Velculescu VE: The colorectal microRNAome. Proc Natl Acad Sci U S A 2006;103:3687-3692.
23. Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009;9:374.
24. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM, Boardman LA, Cunningham JM: Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. Bmc Cancer 2009;9:401-401.
25. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zollner H, Munding J, Klein-Scory S, Reinacher-Schick A, Schwarte-Waldhoff I, Schmiegel W, Hahn SA: MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 2012;33:732-739.
26. Zhong M, Bian Z, Wu Z: miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma. Cell Physiol Biochem 2013;31:209-218.
27. Zhang Q, Tang Q, Qin D, Yu L, Huang R, Lv G, Zou Z, Jiang XC, Zou C, Liu W, Luo J, Zhao Z, Muhammad S, Wang G, Chen YG, Wang X: Role of microRNA 30a targeting insulin receptor substrate 2 in colorectal tumorigenesis. Mol Cell Biol 2015;35:988-1000.
28. Zhao Y, Miao G, Li Y, Isaji T, Gu J, Li J, Qi R: MicroRNA-130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin beta1 [corrected]. PLoS One 2014;9:e87938.
29. Braun J, Hoang-Vu C, Dralle H, Huttelmaier S: Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 2010;29:4237-4244.
30. Brabletz T: To differentiate or not-routes towards metastasis. Nature Reviews Cancer 2012;12:425-436.
31. Lee JM, Dedhar S, Kalluri R, Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006;172:973-981.
32. Peinado H, Olmeda D, Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-428.
33. Zeisberg M, Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009;119:1429-1437.
34. Wang B, Li W, Liu H, Yang L, Liao Q, Cui S, Wang H, Zhao L: miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial-mesenchymal transition. Cell Death Dis 2014;5:e1335.
35. Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR: NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 1996;32:315-317.
36. Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols 2008;3:1101-1108.
37. Ilya I, Sashwati R, Sen CK: Algorithms for mapping of mRNA targets for microRNA. Dna & Cell Biology 2007;26:265-272.
38. Zhao L, Xu J, Liang F, Li A, Zhang Y, Sun J: Effect of Chronic Psychological Stress on Liver Metastasis of Colon Cancer in Mice. PLoS One 2015;10:e0139978.
39. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
40. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006;103:2257-2261.
41. Hood JD, Cheresh DA: Role of integrins in cell invasion and migration. Nat Rev Cancer 2002;2:91-100.
42. Guo W, Giancotti FG: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-826.
43. Switala-Jelen K, Dabrowska K, Opolski A, Lipinska L, Nowaczyk M, Gorski A:The biological functions of beta3 integrins. Folia Biologica 2004;50:143-152.
44. Guan JL: Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol 1997;29:1085-1096.
45. Yang C, Li LI, Wang C, Chen LH, Feng LI, Yan L, Cheng H: Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol Cell Biol1996;16:2606-2613.
46. Niels R, Wenbiao L, Ahmad SA, Fan F, Oliver S, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF: Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Research 2003;63:2079-2087.
47. Lei Y, Huang K, Gao C, Lau QC, Pan H, Xie K, Li J, Liu R, Zhang T, Xie N, Nai HS, Wu H, Dong Q, Zhao X, Nice EC, Huang C, Wei Y: Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells. Mol Cell Proteomics 2011;10:M110005397.
48. Zha R, Guo W, Zhang Z, Qiu Z, Wang Q, Ding J, Huang S, Chen T, Gu J, Yao M, He X: Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin beta1 in hepatocellular carcinoma. PLoS One 2014;9:e87665.
49. Sun L, Liu B, Lin Z, Yao Y, Chen Y, Li Y, Chen J, Yu D, Tang Z, Wang B, Zeng S, Fan S, Wang Y, Li Y, Song E, Li J: MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3. Mol Cancer 2015;14:96.